The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities
Open accessAbstract
Candida auris, a recently recognized, often multidrug-resistant yeast, has become a significant fungal pathogen due to its ability to cause invasive infections and outbreaks in healthcare facilities which have been difficult to control and treat. The extraordinary abilities of C. auris to easily contaminate the environment around colonized patients and persist for long periods have recently resulted in major outbreaks in many countries. C. auris resists elimination by robust cleaning and other decontamination procedures, likely due to the formation of ‘dry’ biofilms. Susceptible hospitalized patients, particularly those with multiple comorbidities in intensive care settings, acquire C. auris rather easily from close contact with C. auris-infected patients, their environment, or the equipment used on colonized patients, often with fatal consequences. This review highlights the lessons learned from recent studies on the epidemiology, diagnosis, pathogenesis, susceptibility, and molecular basis of resistance to antifungal drugs and infection control measures to combat the spread of C. auris infections in healthcare facilities. Particular emphasis is given to interventions aiming to prevent new infections in healthcare facilities, including the screening of susceptible patients for colonization; the cleaning and decontamination of the environment, equipment, and colonized patients; and successful approaches to identify and treat infected patients, particularly during outbreaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Candida auris is an emerging multidrug-resistant fungal pathogen that poses a serious threat to public health.”
From Yeast and filamentous Candida auris stimulate distinct immune responses in the skin (2024) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Candida auris is an emerging multidrug-resistant skin-tropic fungal pathogen that causes serious human infections.”
From The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“C. auris is an emerging fungal pathogen that can cause serious human infections [1,5,38,39].”
From The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“C. auris is an emerging multi-drug-resistant fungal pathogen that can cause fatal infections in humans (1, 19, 20).”
From Differential skin immune responses in mice intradermally infected with Candida auris and Candida albicans (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Candida auris is an emerging multidrug-resistant fungal pathogen that preferentially colonizes and persists in skin tissue”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Candida auris was recently categorized as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) and classified in the critical priority fungal pathogen group by the World Health Organization (1 – 3).”
From Differential skin immune responses in mice intradermally infected with Candida auris and Candida albicans (2023) · cites this paper as [1]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Candida auris: a Review of the Literature
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K. J., Johnson, E. M., Borman, A. M., Candida auris Incident Management Team, Manuel, R. J., & Brown, C. S. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 624
Cited by
Sorted by citations
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
Bino, L. D., Østerlid, K. E., Wu, D., Nonne, F., Romano, M. R., Codée, J. D. C., & Adamo, R. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00021 · Cited by 207
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
Casalini, G., Giacomelli, A., & Antinori, S. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00042-9 · Cited by 217
Rybak, J. M., Barker, K. S., Muñoz, J. F., Parker, J. E., Ahmad, S., Mokaddas, E., Abdullah, A., Elhagracy, R. S., Kelly, S. L., Cuomo, C. A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.024 · Cited by 120
Self-citationCandida auris Outbreaks: Current Status and Future Perspectives
Gaetano, S. D., Midiri, A., Mancuso, G., Avola, M. G., & Biondo, C. (2024) · Microorganisms · doi:10.3390/microorganisms12050927 · Cited by 117
Czechowicz, P., Nowicka, J., & Gościniak, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115895 · Cited by 122
Metadata
- Authors
- Ahmad, S., & Alfouzan, W.
- Affiliations
- Kuwait University (KW)
- Corresponding author
- Ahmad, Suhail
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2021-04-11
- Volume
- 9
- Issue
- 4
- Pages
- 807
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC8069182
- OpenAlex
- W3156847645
- Cited by
- 269
- References
- 187
- Citations by year
- 2026: 55 · 2025: 68 · 2024: 62 · 2023: 53 · 2022: 18 · 2021: 13
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Kuwait University (MI 01/15)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, multidrug resistance, antifungal susceptibility, antifungal resistance mechanisms, nosocomial infections, infection control, environmental contamination, intensive care unit, colonization screening, decontamination, pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
